Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma

Scientific Reports

Volumn 9, Issue 1, 2019, Pages

  Abu Ghanem, Yasmin ^a,b   Dotan, Zohar ^a,b   Zilberman, Dorit E ^a,b   Kaver, Issac ^a,b   Ramon, Jacob ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; AGED; BLOOD TRANSFUSION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KIDNEY TUMOR; MALE; MIDDLE AGED; MORTALITY; NEPHRECTOMY; POSTOPERATIVE PERIOD; RENAL CELL CARCINOMA; TUMOR RECURRENCE;

AGED; BLOOD TRANSFUSION; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; POSTOPERATIVE PERIOD;

EID: 85061031671     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-37691-4     Document Type: Article

References (25)

1. Luan, H., Ye, F., Wu, L., Zhou, Y. & Jiang, J. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis. BMC Surgery, 10.1186/1471-2482-14-34 (2014)
2. Acheson, A. G., Brookes, M. J. & Spahn, D. R. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann. Surg. 256, 235–44 (2012)
3. Linder, B. J. et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur. Urol. 63, 839–45 (2013)
4. Mermershtain, W., Eidelberg, I., Yusim, I., Ariad, S. & Kaneti, J. Perioperative Homologous Blood Transfusion and Survival in Patients with Surgically Treated Renal Cell Carcinoma. UroOncology 3, 23–25 (2003)
5. Soubra, A. et al. Effect of perioperative blood transfusion on mortality for major urologic malignancies. Clin. Genitourin. Cancer 13, e173–81 (2015)
6. Linder, B. J. et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int. 114, 368–74 (2014)
7. Colvin, L. A., Fallon, M. T. & Buggy, D. J. Cancer biology, analgesics, and anaesthetics: is there a link? Br. J. Anaesth. 109, 140–3 (2012)
8. Pesta, M., Fichtl, J., Kulda, V., Topolcan, O. & Treska, V. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res. 33, 2239–43 (2013)
9. Abel, E. J. et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur. Urol. 66, 1139–47 (2014)
10. Moschini, M. et al. Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution. Clin. Genitourin. Cancer 13, 562–567 (2015)
11. GILL, I. S. et al. Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J. Urol. 167, 469–476 (2002)
12. Campbell, S. C. & Novick, A. C. Surgical technique and morbidity of elective partial nephrectomy. Semin. Urol. Oncol. 13, 281–7 (1995)
13. Uzzo, R. G. & Novick, A. C. Nephron sparing surgery for renal tumors: indications, techniques, and outcomes. J. Urol. 166, 6–18 (2001)
14. Ljungberg, B., Albiges, L., Bensalah, K., Bex, A. & Gilles, R. H. Guidelines on Renal Cell Carcinoma EAU. Eur. Assoc. Urol. Update. March 2017 (2017)
15. Abu-Ghanem, Y., Zilberman, D. E., Dotan, Z., Kaver, I. & Ramon, J. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma. Urol. Oncol. Semin. Orig. Investig. 36, 12.e15–12.e20 (2018)
16. Blajchman, M. A. Immunomodulatory Effects of Allogeneic Blood Transfusions: Clinical Manifestations and Mechanisms. Vox Sang. 74, 315–319 (1998)
17. Cata, J. P., Wang, H., Gottumukkala, V., Reuben, J. & Sessler, D. I. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br. J. Anaesth. 110, 690–701 (2013)
18. Ejaz, A., Spolverato, G., Kim, Y., Frank, S. M. & Pawlik, T. M. Variation in triggers and use of perioperative blood transfusion in major gastrointestinal surgery. Br. J. Surg. 101, 1424–1433 (2014)
19. Vamvakas, E. C. & Blajchman, M. A. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 21, 327–348 (2007)
20. Bernard, A. C., Davenport, D. L., Chang, P. K., Vaughan, T. B. & Zwischenberger, J. B. Intraoperative Transfusion of 1 U to 2 U Packed Red Blood Cells Is Associated with Increased 30-Day Mortality, Surgical-Site Infection, Pneumonia, and Sepsis in General Surgery Patients. J. Am. Coll. Surg. 208, 931–937.e2 (2009)
21. Frank, S. M. et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 117, 99–106 (2012)
22. Liu, L. et al. Perioperative allogeneic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One 8, e64261 (2013)
23. Mavros, M. N. et al. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Ann. Surg. Oncol. 22, 4382–4391 (2015)
24. Moschini, M. et al. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. Urol. Oncol. Semin. Orig. Investig. 34, 256.e7–256.e13 (2016)
25. Moschini, M. et al. Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy. Clin. Genitourin. Cancer 15, e681–e688 (2017)